Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -14.74% is 63% above its 5-year average of -40.05%, near the high end of its 5-year range (-71.47%–-3.61%).
10.74% above its 12-month average of -16.51%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.61%.
OPERATING MARGIN
-14.74%
OPERATING MARGIN AVG TTM
-16.51%
OPERATING MARGIN AVG 3Y
-31.84%
OPERATING MARGIN AVG 5Y
-40.05%
OPERATING MARGIN AVG 10Y
-39.77%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+10.74%
CURRENT VS 3Y AVG
+53.71%
CURRENT VS 5Y AVG
+63.20%
CURRENT VS 10Y AVG
+62.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Neuronetics, Inc.
Market Cap
$154.83M
Operating Margin
-14.74%
TTM Avg
-16.51%
3Y Avg
-31.84%
5Y Avg
-40.05%
Market Cap
$152.82M
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$156.90M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
Market Cap
$159.22M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$149.89M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$160.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.75%
Market Cap
$148.97M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$147.35M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | $154.83M | -14.74% | -16.51% | -31.84% | -40.05% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | 0.00% | 0.00% | 0.00% |
| Inogen, Inc. (INGN)vs › | $156.90M | -8.45% | -10.66% | -19.64% | -13.31% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -9.35% | -5.78% | -14.39% | -45.18% |
| Veraxa Biotech Holding AG (VRXA)vs › | $149.89M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.03M | 0.00% | 0.00% | 0.00% | 0.75% |
| PepGen Inc. (PEPG)vs › | $160.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Codexis, Inc. (CDXS)vs › | $148.97M | -54.46% | -76.53% | -68.82% | -55.26% |
| Anavex Life Sciences Corp. (AVXL)vs › | $147.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $148.69M | 0.00% | 0.00% | 0.00% | -615.66% |
Gross Margin
49.1%
Operating Margin
-14.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3.61% |
| 2026-03-31 | -26.11% |
| 2025-12-31 | -12.07% |
| 2025-09-30 | -19.63% |
| 2025-06-30 | -21.15% |
| 2025-03-31 | -34.45% |
| 2024-12-31 | -51.00% |
| 2024-09-30 | -41.71% |
| 2024-06-30 | -51.71% |
| 2024-03-31 | -39.38% |
| 2023-12-31 | -21.79% |
| 2023-09-30 | -49.60% |
| 2023-06-30 | -41.73% |
| 2023-03-31 | -63.75% |
| 2022-12-31 | -42.46% |
| 2022-09-30 | -45.18% |
| 2022-06-30 | -59.99% |
| 2022-03-31 | -71.47% |
| 2021-12-31 | -45.99% |
| 2021-09-30 | -52.05% |
| 2021-06-30 | -46.22% |
| 2021-03-31 | -56.23% |
| 2020-12-31 | -17.07% |
| 2020-09-30 | -19.47% |
| 2020-06-30 | -70.41% |
| 2020-03-31 | -90.33% |
| 2019-12-31 | -39.98% |
| 2019-09-30 | -39.55% |
| 2019-06-30 | -39.87% |
| 2019-03-31 | -55.44% |
| 2018-12-31 | -36.21% |
| 2018-09-30 | -31.54% |
| 2018-06-30 | -39.51% |
| 2018-03-31 | -45.36% |
| 2017-12-31 | -34.96% |
| 2017-09-30 | -26.78% |
| 2017-06-30 | -25.00% |
| 2017-03-31 | -52.99% |
